Seeking Alpha's Biotech Weekly: Celgene-Juno, Gilead's HIV NDA, Happy 4th!
SA Editor Mike Taylor - Seeking Alpha - Thu Jul 02, 3:00PM CDT
A holiday-shortened week still left biotech investors with plenty to chew over. The start of a decade-long collaboration between Celgene ( CELG ) and Juno Therapeutics ( JUNO ) prompted a new wave of enthusiasm for an already well appreciated CAR-T...
CRMD: 3.78 (+0.16), SGYP: 9.13 (+0.49), MNK: 122.44 (+2.18), BIIB: 388.23 (-11.06), OCAT: 5.22 (+0.14), VRX: 232.32 (+8.93), PRGO: 180.86 (+0.85), VRTX: 122.95 (+2.06), GALT: 2.67 (+0.12), IBB: 372.80 (+6.06), MNKD: 5.38 (+0.25), HNT: 69.12 (+2.32), CELG: 118.84 (+1.97), CNC: 72.91 (+2.06), JNJ: 99.53 (+1.13), MDCO: 32.73 (-0.24), GILD: 113.74 (+0.38), GERN: 4.22 (+0.13), JUNO: 52.05 (+1.72), BXLT: 30.85 (+0.79), EXEL: 3.68 (+0.25), NVS: 103.22 (+3.20)
Multiple bidders in the mix for Boehringer Ingelheim's U.S. generics unit; business could fetch $2.2B
Seeking Alpha - at Seeking Alpha - Tue Jun 30, 9:08AM CDT
MNK: 122.44 (+2.18), PRGO: 180.86 (+0.85)
Hikma Founder and Honorary Life President Samih Darwazah Passes Away
PR Newswire - Mon May 18, 7:04AM CDT
Hikma Pharmaceuticals PLC ("Hikma"
Hikma to Launch Colchicine 0.6mg Capsules
PR Newswire - Fri Jan 09, 5:10PM CST
Hikma Pharmaceuticals PLC ("Hikma"
Portfolio Update: The Good, The Bad, The Ugly!
Nick Mackintosh - at Seeking Alpha - Wed Jan 07, 12:04AM CST
BTI: 112.52 (+3.75), CCL: 50.58 (+1.38), DX: 7.55 (+0.05), XL: 37.96 (+0.58), DEO: 118.94 (+3.94), RYAAY: 73.25 (+1.50), BHP: 39.47 (+1.07), SHPG: 250.34 (+7.35), BP: 39.90 (+0.77), AMZN: 443.51 (+9.12), WPPGY: 115.55 (+4.68), UL: 44.65 (+1.64), GSK: 42.45 (+0.65), AZN: 66.45 (+1.90), NGG: 66.43 (+1.67)